I-Mab - ADR

NASDAQ:IMAB   3:59:45 PM EDT
62.17
+0.10 (+0.16%)
Products

Morphosys, I-Mab Announce FDA Clearance For Mor210/Tj210 In Patients With Advanced Cancer

Published: 09/17/2020 20:15 GMT
I-Mab - ADR (IMAB) - Dgap-news: Morphosys and I-mab Announce FDA Clearance of Ind Application for Mor210/tj210 in Patients With Advanced Cancer.
Phase 1 Clinical Study Expected to Start in Q4 2020.